[Systematic review of treatment alternatives for depressed adults with early adverse stress].

Tratamiento de la depresión en adultos con estrés adverso temprano: revisión sistemática de su efecto en síntomas relacionados a trauma, ansiedad, desajuste social y calidad de vida.

Journal

Revista medica de Chile
ISSN: 0717-6163
Titre abrégé: Rev Med Chil
Pays: Chile
ID NLM: 0404312

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 14 04 2021
accepted: 19 08 2021
entrez: 23 3 2022
pubmed: 24 3 2022
medline: 26 3 2022
Statut: ppublish

Résumé

Early adverse stress is a risk factor for the appearance of mental health ailments during adulthood. To systematically review treatment outcomes on mental health symptoms and functional domains, and of interventions aimed at treating adults with depressive disorders and early adverse stress (EAS). Systematic review and meta-analysis including experimental and quasi-experimental published studies indexed in the CINAHL, EMBASE, PubMed, and Web of Science databases, which explored the effectiveness of treatment interventions for depressive disorders in adults exposed to EAS. Data on outcomes was extracted from the included studies. A narrative, qualitative approach or a quality-effects model for meta-analysis were used for synthesizing these data. Thirteen studies were included. Psychological or combined treatment interventions for depression in adults exposed to EAS may be effective in reducing trauma-related symptoms and social dysfunction in the short-and mid-term, with small effect size and without substantive heterogeneity. The assessment of anxiety symptoms and health-related quality of life yielded mixed results. Despite the ubiquity of EAS and its adverse and long-lasting consequences for well-being and health, treatment alternatives are scant. This review suggests that there are treatment interventions for depression in adults exposed to EAS that may achieve integral mental health benefits, alleviating its impact on various symptoms and functional domains, when EAS is explicitly considered in the treatment intervention.

Sections du résumé

BACKGROUND BACKGROUND
Early adverse stress is a risk factor for the appearance of mental health ailments during adulthood.
AIM OBJECTIVE
To systematically review treatment outcomes on mental health symptoms and functional domains, and of interventions aimed at treating adults with depressive disorders and early adverse stress (EAS).
MATERIAL AND METHODS METHODS
Systematic review and meta-analysis including experimental and quasi-experimental published studies indexed in the CINAHL, EMBASE, PubMed, and Web of Science databases, which explored the effectiveness of treatment interventions for depressive disorders in adults exposed to EAS. Data on outcomes was extracted from the included studies. A narrative, qualitative approach or a quality-effects model for meta-analysis were used for synthesizing these data.
RESULTS RESULTS
Thirteen studies were included. Psychological or combined treatment interventions for depression in adults exposed to EAS may be effective in reducing trauma-related symptoms and social dysfunction in the short-and mid-term, with small effect size and without substantive heterogeneity. The assessment of anxiety symptoms and health-related quality of life yielded mixed results.
CONCLUSIONS CONCLUSIONS
Despite the ubiquity of EAS and its adverse and long-lasting consequences for well-being and health, treatment alternatives are scant. This review suggests that there are treatment interventions for depression in adults exposed to EAS that may achieve integral mental health benefits, alleviating its impact on various symptoms and functional domains, when EAS is explicitly considered in the treatment intervention.

Identifiants

pubmed: 35319637
pii: S0034-98872021001001473
doi: 10.4067/s0034-98872021001001473
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

spa

Sous-ensembles de citation

IM

Pagination

1473-1484

Auteurs

Pablo Martínez (P)

Clinical & Research Group, Santiago, Chile.

Sergio Gloger (S)

Clinical & Research Group, Santiago, Chile.

Dante Diez de Medina (D)

Clinical & Research Group, Santiago, Chile.

Arantza González (A)

Clinical & Research Group, Santiago, Chile.

María I Carrasco (MI)

Clinical & Research Group, Santiago, Chile.

Paul A Vöhringer (PA)

Clinical & Research Group, Santiago, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH